InvestorsHub Logo

BTH

10/29/10 9:52 AM

#3021 RE: DonShimoda #3019

You're making just another bogus argument.



How am I making a bogus argument?

The poster was referencing all trials (not a comparison with sarcoma versus RCC) saying that very few trials are stopped.


I asked a question about those two trials. Has nothing to do with comparing RCC versus sarcoma which are two, clearly different cell-lines. I'd like to know his line of thinking.